Target intelligence / Profile preview

Multiple viral structural components

Molecular classification
Viral protein, Structural protein, Glycoprotein, Lipoprotein
01

Overview

Multiple viral structural components refers to the collective set of proteins and lipids that constitute the physical architecture of a virus, including the capsid, envelope, and surface glycoproteins [2, 4]. These components are essential for the viral life cycle, serving to protect the genetic material, facilitate attachment to host cell receptors, and enable the fusion of viral and cellular membranes [2, 6]. In therapeutic contexts, targeting multiple structural elements is a strategy employed by broad-spectrum antivirals and whole-virus vaccines to provide comprehensive protection and reduce the likelihood of viral escape through single-point mutations [4, 5]. For instance, physical agents like ultraviolet (UV) radiation act by damaging multiple structural proteins and nucleic acids simultaneously to inactivate the pathogen [2, 4]. Drugs such as umifenovir are also described as interacting with multiple viral components, including hemagglutinin and lipid membranes, to inhibit entry across a range of viruses. While specific inhibitors typically target a single protein, the term 'multiple viral structural components' describes a broader approach to neutralizing viral particles, making it a critical concept in managing emerging infectious diseases.

Other names
Viral structural proteinsViral particle componentsCapsid and envelope proteinsViral structural elements
02

Mechanism of action

Inhibition of viral-cell membrane fusion, disruption of the viral envelope or capsid integrity, and non-specific binding to multiple surface epitopes to prevent host cell attachment and entry.

03

Biological functions

Viral attachmentViral entryViral assemblyGenome protectionMembrane fusion
04

Disease associations

Infection
05

Safety considerations

Off-target effects on host cell membranesPotential for incomplete viral inactivation in vaccine preparationsBroad-spectrum resistance developmentImmunogenicity concerns or antibody-dependent enhancement
06

Interacting drugs

Umifenovir

4 more in the full profile.

07

Biomarkers

Viral loadNeutralizing antibody titersViral protein levelsSeroconversion rate

Beyond the preview

Go deeper on Multiple viral structural components.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multiple viral structural components.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call